As of 2024-12-15, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -11.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 1,738.92 mil USD. WVE's TTM EBITDA according to its financial statements is -146.72 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 0.7x | 0.6x |
| Forward P/E multiples | 0.4x - 0.7x | 0.6x |
| Fair Price | 1.62 - 1.40 | 1.51 |
| Upside | -88.0% - -89.6% | -88.8% |
| Date | EV/EBITDA |
| 2024-12-11 | -13.90 |
| 2024-12-10 | -13.44 |
| 2024-12-09 | -13.64 |
| 2024-12-06 | -13.75 |
| 2024-12-05 | -12.89 |
| 2024-12-04 | -12.95 |
| 2024-12-03 | -12.48 |
| 2024-12-02 | -13.75 |
| 2024-11-29 | -13.58 |
| 2024-11-27 | -13.46 |
| 2024-11-26 | -13.30 |
| 2024-11-25 | -13.36 |
| 2024-11-22 | -12.72 |
| 2024-11-21 | -12.80 |
| 2024-11-20 | -12.70 |
| 2024-11-19 | -12.65 |
| 2024-11-18 | -11.24 |
| 2024-11-15 | -12.09 |
| 2024-11-14 | -13.47 |
| 2024-11-13 | -14.19 |
| 2024-11-12 | -14.40 |
| 2024-11-11 | -14.97 |
| 2024-11-08 | -14.97 |
| 2024-11-07 | -13.30 |
| 2024-11-06 | -12.64 |
| 2024-11-05 | -12.27 |
| 2024-11-04 | -12.22 |
| 2024-11-01 | -12.26 |
| 2024-10-31 | -12.13 |
| 2024-10-30 | -12.77 |
| 2024-10-29 | -13.27 |
| 2024-10-28 | -13.46 |
| 2024-10-25 | -12.90 |
| 2024-10-24 | -13.29 |
| 2024-10-23 | -13.13 |
| 2024-10-22 | -13.30 |
| 2024-10-21 | -13.59 |
| 2024-10-18 | -13.80 |
| 2024-10-17 | -13.07 |
| 2024-10-16 | -13.37 |
| 2024-10-15 | -6.78 |
| 2024-10-14 | -6.96 |
| 2024-10-11 | -6.83 |
| 2024-10-10 | -6.47 |
| 2024-10-09 | -6.62 |
| 2024-10-08 | -6.20 |
| 2024-10-07 | -6.24 |
| 2024-10-04 | -6.62 |
| 2024-10-03 | -6.72 |
| 2024-10-02 | -7.06 |